+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capricor Therapeutics - logo

Capricor Therapeutics focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials. It is also developing Exosomes for the treatment of cardiovascular and non-cardiovascular diseases. The company was founded in 2005 and is headquartered in Beverly Hills, California.

From
From
From
From
From
From
From
From
Bone Marrow Transplant Rejection - Pipeline Review, H2 2020 - Product Thumbnail Image

Bone Marrow Transplant Rejection - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 797 pages
From
From
From
The Market for Stem Cell Exosomes - Product Thumbnail Image

The Market for Stem Cell Exosomes

  • Report
  • December 2017
  • 134 Pages
From
From
From
The Global Market for Stem Cells - Product Thumbnail Image

The Global Market for Stem Cells

  • Report
  • March 2018
  • 162 Pages
From
From
From
Loading Indicator
adroll